Review
Aug 2026
Biomarker-Driven Insights into Immune Checkpoint Inhibitor Therapy in Small-Cell Lung Cancer.
The pivotal roles of biomarkers in SCLC are highlighted, underscoring their contributions to treatment resistance across tumor-intrinsic mechanisms, immune landscape of the tumor microenvironment (TME) and systemic host factors.
Shu-Xing Wang, Xin-rui Zhao, Yue-Yue Zeng et al.
· Critical reviews in oncology... · 0 citations